IL33 and breast carcinoma: Although other studies, such as breast cancer patients (28), gastric cancer patients (29), found that IL-33 in serum was increased, IL-33 was not detected in the serum of patients with normal, esophagitis and EAC, suggesting that it is not suitable to be used as a serum marker for screening EAC.